Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory

We came across a bullish thesis on Sarepta Therapeutics, Inc. on Stock Region Research’s Substack by Stock Region. In this article, we will summarize the bulls’ thesis on SRPT. Sarepta Therapeutics, Inc.'s share was trading at $17.23 as of June 26^th. SRPT’s trailing and forward P/E were 169.47 and 9.84 respectively according to Yahoo Finance.

[caption id="attachment_1231039" align="aligncenter" width="768"] A researcher studying a microscopic image of a gene therapy under a microscope.[/caption]

Sarepta Therapeutics faced a significant setback recently, with its stock...